BXRX Baudax Bio

Baudax Bio (OTCMKTS:BXRXV) Shares Down 18.1%

Baudax Bio, Inc. (OTCMKTS:BXRXV – Get Rating) fell 18.1% on Tuesday . The stock traded as low as $4.51 and last traded at $4.51. 119,000 shares traded hands during trading, an increase of 124% from t

15:04

GMBL, THMO and HLBZ Among Mid-day Movers

01-26 02:01

Baudax Bio Shares Drop 17% After Tuesday Rise on BX-1000 Trial Results

By Chris Wack Baudax Bio Inc. shares were down 17%, to $3.48 Wednesday, one day after the company said the first interim analysis of a Phase 2 trial of its blocking agent BX1000 had a successful tria

01-26 01:12

Intuitive Surgical, Fisker, Li-Cycle Holdings Among Premarket Losers' Pack

01-25 21:46

Analysts' Opinions Are Mixed on These Healthcare Stocks: Axcella Health (AXLA) and Baudax Bio (BXRX)

01-25 21:15

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

GainersSonoma Pharmaceuticals (NASDAQ:SNOA) stock rose 80.0% to $2.16 during Wednesday's pre-market session. The company's market cap stands at $6.7 million. First Wave BioPharma (NASDAQ:FWBI) stock m

01-25 21:06

Top Midday Gainers

01:30 PM EST, 01/24/2023 (MT Newswires) -- bioAffinity Technologies (BIAF) said results from a trial for its non-invasive diagnostic, CyPath Lung, showed 92% sensitivity and 87% specificity in high-ri

01-25 02:30

12 Health Care Stocks Moving In Tuesday's Intraday Session

GainersbioAffinity Technologies (NASDAQ:BIAF) shares increased by 115.1% to $3.42 during Tuesday's regular session. Trading volume for this security as of 12:30 EST is 49.0 million, which is 74713.3%

01-25 01:31

Why Baudax Bio Shares Trading Higher Today

Baudax Bio Inc (NASDAQ:BXRX) announced the outcome of its first interim analysis in a Phase 2 trial of BX1000 for neuromuscular blockade (NMB) in patients undergoing elective surgery.The trial evaluat

01-25 00:41

Baudax Bio Soars on Promising Phase 2 Data for BX1000

01-24 23:25